Amarantus Bioscience Holdings Inc Press Releases

AMBS 
$0.07
*  
unch
unch
Get AMBS Alerts
*Delayed - data as of May 2, 2016 15:19 ET  -  Find a broker to begin trading AMBS now


Community Rating:
View:    AMBS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Retired American Burn Association President Dr. David Ahrenholz to Present on Engineered Skin Substitute (ESS) at the Vatican's Third International Conference on the Progress of Regenerative Medicine and its Cultural Impact
4/25/2016 8:00:00 AM - PR Newswire
▲16.67 % Price Change since this news event. The Volume Ratio is 0.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Announces Capital Infusion
4/21/2016 4:02:00 PM - PR Newswire
unchange Price Change since this news event. The Volume Ratio is 4.67.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Announces Cancellation of Special Meeting of Shareholders
3/22/2016 8:00:00 AM - PR Newswire
unchange Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avant Diagnostics, Amarantus Diagnostics and Theranostics Health Provide Updated Information for Conference Call to Discuss Business Combination
3/7/2016 3:30:00 PM - PR Newswire
▼-41.67 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
3/7/2016 8:53:00 AM - PR Newswire
▼-36.36 % Price Change since this news event. The Volume Ratio is 4.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Diagnostics and Avant Diagnostics to Form 3-Way Business Combination with Theranostics Health
3/7/2016 8:00:00 AM - PR Newswire
▼-36.36 % Price Change since this news event. The Volume Ratio is 7.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Appoints Brian E. Harvey, MD PhD to Strategic Advisory Board
3/4/2016 1:00:00 PM - PR Newswire
▼-41.67 % Price Change since this news event. The Volume Ratio is 3.19.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Receives Notices of Allowance from European Patent Office for MANF and CDNF in the Treatment of Retinal Disorders
2/29/2016 7:30:00 AM - PR Newswire
▼-30.00 % Price Change since this news event. The Volume Ratio is 1.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus and Lonza Walkersville, Inc. Provide Update on cGMP Manufacturing Readiness for the Engineered Skin Substitute (ESS) Program
2/22/2016 6:00:00 AM - PR Newswire
▼-56.25 % Price Change since this news event. The Volume Ratio is 6.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Announces $3M Capital Infusion
2/19/2016 6:37:00 PM - PR Newswire
▼-56.25 % Price Change since this news event. The Volume Ratio is 3.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson''s Disease Levodopa-Induced Dyskinesia
2/10/2016 7:45:00 AM - PR Newswire
▼-66.67 % Price Change since this news event. The Volume Ratio is 1.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
2/9/2016 2:23:00 PM - PR Newswire
▼-66.67 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
2/5/2016 8:30:00 AM - PR Newswire
▼-75.86 % Price Change since this news event. The Volume Ratio is 1.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amarantus Receives Dual Notices of Allowance from European Patent Office for Engineered Skin Substitute (ESS)
2/3/2016 9:00:00 AM - PR Newswire
▼-72.00 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day